The global non-invasive prenatal testing market is expected to generate $1.4 billion revenue by 2020, and is projected to progress at a CAGR of 17.6% during the forecast period. The market growth is attributed to the rising incident cases of chromosome syndrome, increasing expenditure in the research and development (R&D) sector, and growing demand for early and non-invasive fetal testing.
Chromosome syndromes such as Edwards syndrome and Down syndrome are caused due to genetic mutations in human beings. According to an article published by the World Health Organization (WHO), nearly 3,000-5,000 infants are born with chromosome disorders, thereby, resulting in increasing need for advanced and early prenatal testing, which, in turn, is positively impacting the growth of the non-invasive prenatal testing market.
On the basis of test type, MaterniT21 PLUS held the largest share in 2014 in the non-invasive prenatal testing market. In addition, it was the first diagnostic test introduced in the market for Down syndrome. However, the NIFTY category is likely to witness fastest growth during the forecast period.
Increasing strategic development activities like partnerships and collaborations is an evolving trend in the global market, thereby, ensuring cost-effectiveness, faster availability, and genetic solutions to support education system. However, stringent regulatory guidelines are hindering the growth of global market. To counter this restraint, public and private associations in developing nations such as India and China are taking effective measures to improve healthcare facilities and raise awareness about NIPT, thus, making Asia-Pacific (APAC) the fastest region in the non-invasive prenatal testing market, registering a CAGR of 18.1% during the forecast period.
Illumina Inc., LifeCodexx AG, Sequenom Inc., Quest Diagnostics Incorporated, Natera Inc., Hoffmann-La Roche Ltd., Berry Genomics Co. Ltd., BGI, and Laboratory Corporation of America Holdings are some of the key players in the global non-invasive prenatal testing market.
NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SEGMENTATION
Market Segmentation by Test Type
Market Segmentation by Geography